Response of cyclophosphamide-treated broiler chickens to challenge with velogenic Newcastle disease virus

Amarachukwu O. Igwe,Ismaila Shittu,John O. A. Okoye
DOI: https://doi.org/10.1080/09712119.2018.1434078
2018-01-01
Journal of Applied Animal Research
Abstract:This study investigated whether prior cyclophosphamide (CY) treatment influenced the susceptibility of young broiler chickens to velogenic Newcastle disease (vND) virus (vNDV) challenge. Broiler chickens treated with CY at 4 weeks of age showed a loss of weight, severe atrophy of the bursa and thymus and severe lymphocytic depletion in the bursa, spleen and thymus and lymphopaenia. On challenge at 6 weeks of age with vNDV, there were significant (p < .05) weight loss, severe depression, diarrhoea, coughing and sero-mucous nasal discharges and torticollis. Lesions included severe atrophy of the lymphoid organs and congested lungs. Proventricular, intestinal and caecal tonsil haemorrhages and ulcers were more severe in the CY-untreated than the treated broilers. Histopathology showed severe necrosis and depletion of the lymphocytes in the lymphoid organs, perivascular cuffin and endotheliosis in the brain. Total mortalities in the CY-treated and untreated broilers were 100% and 94.44%, respectively, by day 6 post-challenge. There was no statistical difference (p < .05) between the mortalities. These results show that CY treatment may not have an effect on the susceptibility of broilers to an acute disease like vND.
agriculture, dairy & animal science
What problem does this paper attempt to address?